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SUMMARY
Exquisite regulation of energy homeostasis protects
from nutrient deprivation but causes metabolic
dysfunction upon nutrient excess. In human and mu-
rine adipose tissue, the accumulation of ligands of
the receptor for advanced glycation end products
(RAGE) accompanies obesity, implicating this recep-
tor in energy metabolism. Here, we demonstrate that
mice bearing global- or adipocyte-specific deletion
of Ager, the gene encoding RAGE, display superior
metabolic recovery after fasting, a cold challenge,
or high-fat feeding. The RAGE-dependent mecha-
nisms were traced to suppression of protein kinase
A (PKA)-mediated phosphorylation of its key targets,
hormone-sensitive lipase and p38mitogen-activated
protein kinase, upon b-adrenergic receptor stimula-
tion—processes that dampen the expression and
activity of uncoupling protein 1 (UCP1) and thermo-
genic programs. This work identifies the innate role
of RAGE as a key node in the immunometabolic net-
works that control responses to nutrient supply and
cold challenges, and it unveils opportunities to
harness energy expenditure in environmental and
metabolic stress.
INTRODUCTION
The epidemic of obesity and its metabolic sequelae profoundly
impact human health and longevity (Finkelstein et al., 2009; Fle-
gal et al., 2012). Maintaining a precise balance between energy
intake and expenditure is essential for an organism’s ability to
store or utilize nutrients. Yet, hoarding energy is a double-edged
sword, albeit, salutary in nutrient deprivation; in over-feeding,
excess energy storage confers susceptibility to obesity and
type 2 diabetes.
White adipose tissue (WAT) and brown adipose tissue (BAT) in
mammals store energy in the form of triglycerides and release
fatty acids and glycerol in response to catecholaminergic stim-
ulation by sympathetic nerves (Bartness et al., 2010). Whereas
WAT liberates fatty acids into the circulation, BAT preferentially
oxidizes fatty acids and dissipates energy through uncoupled
respiration and the production of heat (Cannon and Nedergaard,
2001; Collins, 2012). The recent identification of BAT in adult hu-
mans has rekindled an interest in harnessing brown fat to spur
cellular energy expenditure (Nedergaard et al., 2007; van
Marken Lichtenbelt et al., 2009; Cypess et al., 2009; Virtanen
et al., 2009; Zingaretti et al., 2009). The physiologic process in
which energy is dissipated in the form of heat in response to
stressors such as cold challenges or over-feeding is termed
‘‘adaptive thermogenesis’’ and is dependent on the expression
and activity of uncoupling protein 1 (UCP1) in brown adipocytes
(Kopecky et al., 1995). Catecholamines stimulate b-adrenergic
receptors (ARBs), culminating in increased activity of protein
kinase A (PKA) and leading to phosphorylation of adipocyte
lipases, such as hormone-sensitive lipase (HSL) and lipolysis,
and of p38 mitogen-activated protein kinase (MAPK) and regu-
lation of genes linked to lipid oxidation in brown adipocytes,
including Ucp1 and Ppargc1a (peroxisome proliferator-acti-
vated receptor g [PPARg]-coactivator 1a) (Collins, 2012; Ye-
huda-Shnaidman et al., 2010). Though a process classically
ascribed to BAT, during prolonged starvation or a cold chal-
lenge, white adipocytes undergo ‘‘beiging’’ or ‘‘browning,’’ in
which WAT assumes increased UCP1-expressing adipocytes
bearing thermogenic capacity (Kajimura et al., 2015; Lee et al.,
2015b). Despite the profound importance of such metabolic
plasticity, the natural ‘‘brakes’’ in adipose tissues—the best
described of which is insulin (Burns et al., 1979; Jungas and
Ball, 1963, 1964)—remain incompletely understood.
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Figure 1. RAGE Is Expressed in Adipose Tissue and Affects Thermogenic Gene Programs
(A) qRT-PCR for relative Ager mRNA expression was performed in iBAT, iWAT, and eWAT retrieved from 12-week-old male wild-type (WT) C57BL/6 mice fed
standard chow.
(B) Primary adipocytes from iBAT, iWAT, and eWAT of WT mice fed standard chow were subjected to qRT-PCR for detection of relative Ager and Fasn mRNA
expression on day 0, 3, and 8 of differentiation.
(C and D) Core body temperature of 8-week-old male WT or Ager null mice determined in mice housed at (C) thermoneutrality (30C) for 24 h and (D) at room
temperature (23C).
(E) Oxygen consumption rates (OCRs) normalized to total protein were determined in primary adipocytes differentiated from iBAT from WT and Ager null mice.
The means ± SEM are reported from five technical replicates with three biological replicates per group.
(legend continued on next page)
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The immunoglobulin superfamily molecule, the receptor for
advanced glycation end (RAGE) products, binds to a distinct
repertoire of molecules, such as the carboxymethyllysine
(CML)-advanced glycation end products (AGEs), high-mobility
group box 1 (HMGB1), and S100/calgranulins, which accumu-
late in metabolic stress (Lo´pez-Dı´ez et al., 2016; Ramasamy
et al., 2012). Although these ligands are classically linked to
diabetes and inflammation, recent evidence places these mole-
cules and RAGE itself in human and murine obese adipose tis-
sue (Gaens et al., 2014; Song et al., 2014). RAGE localization in
human obese adipose tissue aligns with our recent finding that
mice globally devoid of Ager (the gene encoding RAGE) are pro-
tected from obesity and insulin resistance when fed a high-fat
diet (HFD) compared to wild-type (WT) mice (Song et al.,
2014). Yet, the mediating mechanisms have remained elusive.
Here, we show that mice bearing adipocyte-specific deletion
of Ager display significant protection from HFD-induced obesity
and insulin resistance and exhibit a superior ability to thermoreg-
ulate during a cold challenge, compared to mice in which
adipocytes express Ager. WT mice that underwent a surgical
transplantation of either interscapular BAT (iBAT) or subcutane-
ous inguinal WAT (iWAT) from mice with adipocyte-specific
deletion of Ager demonstrate significant protection from HFD-
induced obesity and insulin resistance, compared to WT mice
transplanted with iBAT or iWAT in which adipocytes expressed
Ager. We traced these adipocyte-intrinsic, RAGE-dependent
mechanisms to RAGE ligand-mediated suppression of PKA-
dependent phosphorylation of HSL and p38 MAPK—processes
that, collectively, dampen UCP1 and thermogenic programs.
RESULTS
RAGE Is Expressed in Mature Adipocytes
We determined the expression patterns of RAGE in WAT and
BAT in WT mice fed standard chow and found that Ager is
expressed in BAT and WAT. Compared to epididymal adipose
tissue (eWAT) or iWAT, a significantly higher expression of
Ager mRNA was observed in iBAT (Figure 1A). In the iWAT and
eWAT depots, a significantly higher expression of Ager mRNA
transcripts was observed in the floating adipocytes than in the
stromal vascular fraction (SVF) (Figure S1A). When preadipo-
cytes from the SVF of iBAT, iWAT, and eWAT were differentiated
into adipocytes, in each depot, a significantly higher expression
of AgermRNA was noted on days 3 or 8 of differentiation versus
day 0, which paralleled time-dependent increases in Fasn, a
marker for adipocyte differentiation (Figure 1B). There were no
discernible differences in the morphology of iBAT-, iWAT-, or
eWAT-derived primary adipocytes or in the neutral lipid content
on day 7 of differentiation from eWAT-derived adipocytes (Fig-
ures S1B and S1C). Thus, increasing Ager expression accom-
panies, but is not required for, the differentiation of primary
adipocytes from iBAT, iWAT, and eWAT.
Deletion of Ager Increases Adipocyte Thermogenic
Gene Programs and Mitochondrial Activity
Although core body temperature at thermoneutrality (30C) did
not differ between the WT and Ager null mice (Figure 1C), at
room temperature, mice devoid of Ager displayed a significantly
higher core body temperature than the WT mice (Figure 1D).
Body weight, adiposity, and plasma norepinephrine levels did
not differ between the Ager null and the WT mice fed standard
chow (Figures S1D–S1H).
As the highest expression of Ager in the adipose depots was in
iBAT, we probed the effect of Ager deletion on mitochondrial
function in iBAT-derived primary adipocytes frommice fed stan-
dard chow. Basal respiration rates and ATP production were
significantly higher in adipocytes derived from Ager null than
from WT mice (Figure 1E). The adipocytes derived from Ager
null iBAT exhibited pronounced mitochondrial activity, as as-
sessed by MitoTracker Red CMXRos (Koh et al., 2009) (Fig-
ure S1I). These findings suggest that RAGE contributes to the
regulation of thermogenic programs in iBAT and to browning or
beiging in iWAT.
To address this point, we retrieved adipose tissues from WT
mice and mice globally devoid of Ager fed standard chow at
room temperature. Ager deletion resulted in a significantly higher
expression of thermogenic genes (Prdm16, Ppargc1a, Creb,
Dio2, Cidea, and Ucp1) in iBAT and iWAT. Transcript levels of
Adrb3 were significantly higher in iBAT, but not iWAT, of Ager
null than of WT mice (Figure 1F). Regarding lipolysis (Pnpla2)
and lipogenesis (Fasn, Cebpa, and Pparg), mRNA levels of these
genes were significantly higher in Ager null than in WT iBAT and
iWAT. In relation to mitochondrial properties, levels of Tfam in
iBAT (Lidell et al., 2011), but not iWAT, were significantly higher
in Ager null than in WT mice (Figure 1F), thus suggesting that
mitochondrial biogenesis was higher in iBAT of Ager null than
of WT mice.
Although eWAT is not primarily a thermogenic adipose tissue
depot, we nevertheless examined the above markers. In
eWAT, the levels of Creb, Dio2, Fasn, Cebpa, and Tfam were
significantly higher in Ager null than in WT; there were no differ-
ences in Cidea, Ucp1, Pnpla, and Pparg; and the levels of
Prdm16, Ppargc1a, and Adrb3 were significantly lower in the
eWAT of Ager null than of WT mice (Figure S1J).
RAGE Dampens the Adaptive Response to Fasting and
Cold Challenges
Our findings thus far indicate that the deletion of Ager upregu-
lates adipocyte thermogenic gene programs in iBAT and iWAT.
In adipocytes, b-adrenergic signals upregulate Ucp1 transcrip-
tion, and, in part through lipolysis, the released fatty acids are
(F) iBAT and iWAT retrieved from 8-week-old WT or Ager null mice housed at room temperature were analyzed via qRT-PCR for detection of relative mRNA
expression of Prdm16, Ppargc1a, Creb, Adrb3, Dio2, Cidea, Ucp1, Pnpla2, Fasn, Cebpa, Pparg, and Tfam.
Unless otherwise stated, the data are presented as mean ± SEM in N = 4–5mice/group. Data analysis: (A and B) independent samples one-way ANOVA followed
by a post hoc Tukey’s HSD test; (C and D) two-tailed Student’s t test; and (E, repeatedmeasures, and F, independent samples) two-way ANOVA followed by post
hoc Sidak test; *p < 0.05; **p < 0.01, and ***p < 0.001.
See also Figure S1.
Cell Reports 28, 773–791, July 16, 2019 775
(legend on next page)
776 Cell Reports 28, 773–791, July 16, 2019
proposed to enhance UCP1 activity in themitochondria (Himms-
Hagen et al., 2000; Rial et al., 1983). We tested these concepts in
settings in which adaptive thermogenic programs are engaged.
First, we used a fasting-refeeding paradigm. After 24 h of fast-
ing, WT mice displayed a significantly higher expression of Ager
in iBAT, but not in iWAT. In iBAT, after 24 h of refeeding, the
expression of Ager was significantly lower after fasting and
returned to baseline (fed) levels (Figure 2A). Similar expression
patterns were observed in eWAT under these conditions (Fig-
ure S2A). After 24 h of fasting, mice globally devoid of Ager dis-
played significantly less loss of body temperature than the WT
mice did (Figure 2B). We examined the expression of Acox1
and Cpt2a, genes that are associated with fatty acid beta
oxidation. In iBAT, levels of Acox1 and Cpt2amRNA were signif-
icantly higher in the fasted Ager null than in the WT mice (Fig-
ure 2C), and in iWAT, significantly higher levels of Acox1
mRNA, but not Cpt2a mRNA, were observed in fasted mice
devoid of Ager than in the WT mice (Figure 2D). In eWAT, there
were no genotype-dependent differences in the fed or the fasted
states (Figure S2B).
As an alternative paradigm to induce lipolysis and thermogenic
programs, we performed a cold stress (Duncan et al., 2007).
Compared to room temperature, the cold challenge resulted in
a significantly increased expression of Ager in iBAT after 6 or
12 h at 4C. (Figure 2E). In iWAT and eWAT, Ager expression
was significantly higher after 12 h of exposure to 4C, compared
to room temperature (Figures 2F and S2C). To assess whether
upregulation of Ager in iBAT and iWAT in mice subjected to the
4C cold challenge affected thermoregulation in vivo, we as-
sessed their core body temperature after 48 h of exposure to
4C. Mice devoid of Ager exhibited significantly less loss of
body temperature than did WT mice over 48 h (Figure 2G). In
iBAT, at 6 or 12 h of exposure to 4C, levels of Ucp1 mRNA did
not differ between Ager null and WT mice; at room temperature,
levels ofUcp1mRNA transcripts were significantly higher in Ager
null than in WT iBAT (Figure 2H). In iWAT, levels of Ucp1 mRNA
were significantly higher in Ager null mice at room temperature
and after 6 or 12 h in 4C (Figure 2I). In eWAT, levels of Ucp1
were significantly lower in Ager null than inWTmice at room tem-
perature andafter 6 or 12 h at the 4Ccold challenge (FigureS2D).
Thus, deletion of Ager protects against the loss of body temper-
ature in mice subjected to the 4C environment, which was
accompanied by RAGE-dependent regulation of Ucp1 in iWAT.
Adipocyte-Specific Deletion of Ager Protects from Diet-
Induced Obesity and Cold Challenge
In addition to adipocytes, immune and vascular cells and sympa-
thetic fibers populate adipose tissue and might contribute to the
impact of RAGE expression. To definitively probe for roles for
RAGE in adipocyte-intrinsic responses to the HFD and cold chal-
lenge, we generated Ager floxed mice (Figures S3A and S3B).
Agerflox/flox mice were bred with adiponectin (Adipoq) Cre-re-
combinase mice to yield Agerflox/flox Adipoq Cre (+) (adipocyte-
specific Ager-deleted mice) and littermate Agerflox/flox Adipoq
Cre (–) (Ager WT) mice. This resulted in the deletion of Ager
from iWAT, eWAT, and iBAT, but not from the pancreas, muscle,
and liver (Figure S3C). Hereafter, these animals will be referred to
as Agerflox/flox Cre (+) and Agerflox/flox Cre (–) mice.
We phenotyped male littermate Agerflox/flox Cre (+) and
Agerflox/flox Cre (–) mice at baselinewhile theywere fed a standard
chow diet and then after 6 weeks of HFD feeding (60% kcal/fat).
At baseline, body weight and composition, average food
intake, physical activity, and energy expenditure rates were
indistinguishable between Agerflox/flox Cre (+) (green lines) and
Agerflox/flox Cre (–) (red lines) mice (Figures 3A–3E). However,
when fed a HFD, Agerflox/flox Cre (+) mice weighed significantly
less than Cre (–) mice (Figure 3A). Whole body fat mass,
measured using 1H-MRS, was significantly lower in the
Agerflox/flox Cre (+) than in Cre (–) mice after 3 and 6 weeks of
the HFD (Figure 3B). Average food consumption did not differ
by genotype, except after 6 weeks of the HFD, in which lower
food consumption was noted in Agerflox/flox Cre (+) than in
Cre (–) mice (Figure 3C). No genotype-dependent differences in
physical activity were noted at baseline or after 3 and 6 weeks
of the HFD (Figure 3D). Agerflox/flox Cre (+) mice displayed signif-
icantly higher energy expenditure rates than Cre (–) mice after
3 weeks of the HFD, with trends in the same direction at 6 weeks
of the HFD (Figure 3E). No differences in glucose-tolerance
testing (GTT) were observed after 12 weeks of the HFD (Fig-
ure 3F). Agerflox/flox Cre (+) mice exhibited significantly greater
insulin sensitivity than Cre (–) mice during an insulin-tolerance
test (ITT) after 12 weeks of the HFD (Figures 3G and S3D).
We determined if a modulation of adipose inflammation
accompanied the metabolic protection observed in Agerflox/flox
Cre (+) mice after the HFD. In eWAT, but not iWAT, mRNA levels
of Emr1 (F4/80) and Ccl2 were significantly lower in Agerflox/flox
Cre (+) than in Cre (–) mice (Figure S3E). No differences in Tnfa
Figure 2. Effects of RAGE on Thermogenic Gene Expression during Fasting and Cold Challenge
(A–D) Fasting and refeeding in 11-week-old male WT and Ager null mice.
(A) Ager expression in iBAT and iWAT from WT mice in a fed, fasted (24 h) or 24-h refed state.
(B) Change in core body temperature, [(D) temperature], between the fasted and the refed states was measured in WT or Ager null male mice housed at room
temperature (RT).
(C and D) Relative mRNA expression of Acox1 and Cpt2awas measured by qRT-PCR in (C) iBAT and (D) iWAT from fed and fasted (24 h) WT and Ager null mice.
(E–I) Eight-week-old male WT or Ager null mice were exposed to a cold challenge (4C).
(E and F) iBAT (E) and iWAT (F) from WT mice were subjected to qRT-PCR for relative Ager mRNA expression.
(G) (D) Temperature from baseline (room temperature) and after 48 h at 4C is shown.
(H and I) WT or Ager null mice were housed at room temperature (23C) or exposed to a 4C cold challenge for 6 or 12 h. iBAT (H) and iWAT (I) were dissected
after and subjected to qRT-PCR for detection of relative Ucp1 mRNA expression.
In (B)–(D) and (G)–(I): WT (black bars) and Ager null (green bars) mice. Data are presented as mean ± SEM in N = 4–6 mice/group. Data analysis: (A, E, and F) one-
way ANOVA with post hoc Tukey’s HSD test; (B and G) two-tailed Student’s t test; (C, D, H, and I) two-way ANOVA followed by a post hoc Sidak test or Tukey’s
test, as appropriate; *p < 0.05; **p < 0.01, and ***p < 0.001.
See also Figure S2.
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or Il10 expression were observed in eWAT or iWAT between the
genotypes (Figure S3E). Transcript levels for Irf4, which in-
creases adipocyte lipolysis (Eguchi et al., 2011), were signifi-
cantly higher in the eWAT, iWAT, and iBAT of Agerflox/flox
Cre (+) mice than Cre (–) mice (Figure S3E). Tlr4, which has
been linked to endotoxin-mediated stimulation of lipolysis in
adipocytes (Zu et al., 2009), was significantly higher in eWAT,
iWAT, and iBAT of Agerflox/flox Cre (+) than Cre (–) mice (Fig-
ure S3E), and levels of Tlr2 mRNA were significantly higher in
eWAT and iWAT, not iBAT, of Agerflox/flox Cre (+) than of Cre (–)
mice (Figure S3E). Thus, decreased adipose inflammation
accompanied the observed protection in Agerflox/flox Cre (+)
mice from diet-induced obesity and insulin intolerance.
We next exposed littermate Agerflox/flox Cre (+) and Cre (–)
mice to a cold challenge. Compared to Agerflox/flox Cre (–)
mice, Cre (+) mice exhibited significant protection from a loss
of body temperature after 24 h of exposure to 4C (Figure 3H),
with no genotype-dependent differences observed in body
weight changes (Figure 3I). We examined the expression of
genes associated with thermogenic responses in iBAT and
iWAT after cold exposure. In iBAT, there were no genotype-
dependent differences inUcp1,Dio2, Ppargc1a, orCidea during
the cold challenge, and only significantly lower Ucp1 was
observed in Agerflox/flox Cre (+) at baseline (Figure 3J). In iWAT,
after 24 h of 4C, levels of Ucp1, Dio2, Ppargc1, and Cidea
mRNA were significantly higher in Agerflox/flox Cre (+) than in
Cre (–) mice (Figure 3K). In eWAT, levels of Ucp1 were signifi-
cantly higher in Agerflox/flox Cre (+) than in Cre (–) mice at 4C;
no genotype-dependent differenceswere observed inPpargc1a
mRNA at 4C but the levels of Ucp1 and Ppargc1a were signif-
icantly higher at room temperature in the Agerflox/flox Cre (+) than
the Cre (–) mice (Figure S3F). These data support adipocyte-
intrinsic roles for RAGE in adaptive thermogenic gene program
responses after the HFD and 4C cold challenge.
Transplantation of iBAT or iWAT from Agerflox/flox Cre (+)
Mice into WT Mice Reduces Body Weight Gain and
Upregulates Thermogenic Gene Programs in High-Fat
Feeding
As the Adipoq Cre-recombinase strategy employed above
affected levels of Ager in both brown and white adipocytes,
the relative contribution of each depot could not be discerned.
To address this point, we performed an adipose tissue surgical
transplantation of iBAT bearing adipocyte-specific deleted
Ager or adipocyte-expressing Ager into lean, young, WT mice.
Figure S4A is a representative image demonstrating a well-vas-
cularized, non-necrotic iBAT graft. After 4–5 days’ recovery from
surgery, mice were switched to a HFD and were monitored over
20 weeks. Beginning at 4 weeks post-HFD, body weights in WT
mice receiving Agerflox/flox Cre (+) iBAT were significantly lower
than those of mice receiving Agerflox/flox Cre (–) iBAT, an observa-
tion that continued and was magnified throughout the HFD
feeding period (Figures 4A and 4B). Fat mass was significantly
lower in the WT mice receiving Agerflox/flox Cre (+) versus Cre
(–) iBAT after 14 weeks of the HFD (Figure 4C). Although there
were no differences in food intake or physical activity between
the Agerflox/flox Cre (+) and Cre (–) mice iBAT donors (Figures
4D and 4E), energy expenditure was significantly higher in the
mice receiving Agerflox/flox Cre (+) than those receiving Cre (–)
iBAT after 16 weeks of the HFD (Figure 4F). After 12 weeks of
the HFD, WT mice receiving Agerflox/flox Cre (+) iBAT were more
glucose tolerant than mice receiving Cre (–) iBAT (Figure 4G). In-
sulin sensitivity was improved in mice receiving the Agerflox/flox
Cre (+) than the Cre (–) iBAT (Figures 4H and S4B).
We retrieved native iBAT and iWAT, transplanted iBAT (tiBAT)
and eWAT, and assessed the expression of thermogenic genes
after 20 weeks of a HFD. In native iBAT, the levels ofDio2,Cpt2a,
and Pnpla2 mRNA levels were significantly higher in WT mice
receiving Agerflox/flox Cre (+) than those receiving Cre (–) iBAT,
while levels of Ucp1 and Ppargc1a mRNA were generally, but
not significantly, higher (Figure 4I). Immunohistochemistry re-
vealed that the native iBAT of mice receiving Agerflox/flox Cre (+)
versus Cre (–) iBAT transplants displayed a significantly higher
UCP1-positive area (Figure 4J). In native iWAT, there were no
significant differences in levels of Ucp1, Dio2, Ppargc1a,
Cpt2a, or Pnpla2 mRNA in WT mice receiving Agerflox/flox
Cre (+) versus Cre (–) iBAT transplants (Figure 4K). However, im-
munostaining revealed that the native iWAT of mice that were
transplanted with Agerflox/flox Cre (+) iBAT displayed significantly
higher UCP1-positive areas than mice that had been trans-
planted with Cre (–) iBAT (Figure 4L). In the transplanted iBAT,
levels of Ucp1, Dio2, Ppargc1a, Cpt2a, and Pnpla2 mRNA
were significantly higher in transplanted iBAT originating from
Agerflox/flox Cre (+) than from Cre (–) mice (Figure 4M). In native
eWAT, levels ofUcp1, Ppargc1a,Cpt2a, and Pnpla2mRNA tran-
scripts were significantly higher in the mice receiving Agerflox/flox
Figure 3. Adipocyte-Specific Deletion of Ager Affects HFD-Induced Obesity and Thermoregulatory Responses to a Cold Challenge
(A–G) Eight-week-old male Agerflox/flox Adipoq Cre (–) (red) (Agerflox/flox Cre (–)) and Agerflox/flox Adipoq Cre (+) (green) (Agerflox/flox Cre (+)) mice were fed a HFD
(60% kcal/fat).
(A) Body weight gain after up to 6 weeks of high-fat feeding was recorded.
(B–E) Body composition (B), average food intake (C), physical activity (D), and energy expenditure (E) were assessed in mice fed standard chow (baseline) or after
3 or 6 weeks of a HFD. In (A)–(E), the mean ± SEM is reported in N = 8 mice/group.
(F and G) Glucose (F) and insulin tolerance (G) tests were performed after 12 weeks of a HFD. The mean ± SEM is reported in N = 4–5 mice/group.
(H–K) Eight-week-old male Agerflox/flox Cre (–) and Agerflox/flox Cre (+) mice were housed for 24 h at 4C.
(H and I) (D) Temperature (body temperature at room temperature versus 24 h of 4C) (H) and change in body weight (I) are reported.
(J and K) Relative mRNA expression of Ucp1, Dio2, Ppargc1a, and Cidea mRNA was assessed in (J) iBAT and (K) iWAT retrieved from mice housed at room
temperature or after termination of a 24-h cold challenge (4C).
In (F)–(K), the mean ± SEM is reported in N = 4–5 mice/group. In (A)–(K), Agerflox/flox Cre (–) shown as red and Agerflox/flox Cre (+) shown as green. Data analysis:
(A–G, repeated measures, and J and K, independent samples) two-way ANOVA followed by a post hoc Bonferroni test; (H and I) two-tailed Student’s t test;
*p < 0.05; **p < 0.01, ***p < 0.001, and ****p < 0.0001.
See also Figure S3.
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Cre (+) than those receiving Cre (–) iBAT, while levels of Dio2
mRNA transcripts were significantly lower (Figure S4C). Fig-
ure S4D is a representative image of the secondary antibody-
alone control for the UCP1 immunostaining.
We next transplanted iWAT expressing or devoid of adipocyte
Ager into young, lean, WT mice and established the presence
of vascularized non-necrotic grafts (representative image; Fig-
ure S5A). Four days after the transplantation, mice were
switched to a HFD for an additional 20 weeks. Compared to
recipients of Agerflox/flox Cre (–) iWAT, WT mice receiving
Agerflox/flox Cre (+) iWAT displayed significantly less weight gain
after 12 weeks of the HFD (Figures 5A and 5B). The WT mice re-
cipients ofAgerflox/flox Cre (+) iWAT displayed significantly less fat
mass than recipients of Cre (–) iWAT (Figure 5C). No differences
in food intake or physical activity were observed by iWAT donor
genotype (Figures 5D and 5E). As with iBAT transplants, signifi-
cantly higher energy expenditure was observed in WT recipients
of Agerflox/flox Cre (+) thanCre (–) iWAT after 16 weeks of the HFD
(Figure 5F). The WT mice receiving Agerflox/flox Cre (+) versus
Cre (–) iWAT displayed superior glucose tolerance (Figure 5G)
and insulin sensitivity while on the HFD (Figures 5H and S5B).
After 20 weeks of the HFD, in native iBAT, WT mice receiving
Agerflox/flox Cre (+) versus Cre (–) iWAT displayed a significantly
higher expression of Ppargc1a and Pnpla2 mRNA transcripts,
with no statistically significant differences in levels of Ucp1,
Dio2, or Cpt2amRNA transcripts (Figure 5I). Immunohistochem-
istry revealed that the native iBAT of mice that were transplanted
with Agerflox/flox Cre (+) versus Cre (–) iWAT displayed a signifi-
cantly higher UCP1-positive area (Figure 5J). In native iWAT,
WT mice receiving Agerflox/flox Cre (+) versus Cre (–) iWAT dis-
played significantly higher levels of Ucp1, Dio2, and Pnpla2
mRNA transcripts; significantly lower levels of Ppargc1a
mRNA; and no differences in Cpt2a mRNA transcripts (Fig-
ure 5K). Immunohistochemistry revealed that there were no
significant differences in the UCP1-positive area in the iWAT of
mice that had been transplanted with Agerflox/flox Cre (+) or
Cre (–) iWAT (Figure 5L). In the tiWAT, the WT mice recipients
of Agerflox/flox Cre (+) versus Cre (–) iWAT displayed significantly
higher levels of Ucp1 and Pnpla2 mRNA transcripts, a trend to
higher levels of Dio2 expression, lower levels of Ppargc1a, and
no significant differences inCpt2amRNA transcripts (Figure 5M).
In native eWAT, significantly higher levels of Ucp1, Ppargc1a,
and Pnpla2 mRNA transcripts were observed in the recipients
of Agerflox/flox Cre (+) than of Cre (–) iWAT, with no statistically
significant differences in Dio2 or Cpt2a mRNA transcripts (Fig-
ure S5C). Thus, the deletion of Ager in iBAT or iWAT adipocytes
transmits protection from diet-induced obesity and insulin and
glucose intolerance and enhances expression of thermogenic
genes.
To assess the effects of RAGE ligand sequestration, we previ-
ously treatedWTmice fed aHFD for 18weekswith soluble RAGE
(sRAGE), the extracellular ligand-binding domains of RAGE,
which act as a decoy receptor and thus suppress RAGE
signaling. When treatment was given concurrently with a HFD,
compared to vehicle-treatedmice, mice treated with sRAGE dis-
played less body weight gain (Song et al., 2014). Compared to
vehicle-treated mice, in the iWAT of sRAGE-treated mice, we
noted the following: expression of Ucp1mRNA was significantly
higher; expression ofCideawas significantly higher in the eWAT,
iWAT, and iBAT; expression of Ppargc1amRNAwas significantly
higher in the eWAT and iBAT; and expression of Dio2 mRNA
was significantly higher in eWAT (Figures S6A–S6D). Immunohis-
tochemistry revealed more pronounced UCP1 immunoreactive
epitopes in the eWAT, iWAT, and iBAT of sRAGE-treated
mice (Figure S6E). Thus, both pharmacological and genetic ap-
proaches indicate that RAGE suppresses adipose tissue ther-
mogenic programing.
RAGE Suppresses b3-Adrenergic Stimulation of
Lipolysis and Ucp1mRNA in Adipocytes
Compared to thermoneutrality, exposure to 4C results in signif-
icant increases in sympathetic nerve innervation to the eWAT
and iWAT (Castro et al., 2017). As b-adrenergic stimulation of ad-
ipocytes is a primary mechanism for lipolysis and the generation
of fatty acid products that regulate Ucp1 expression and activity
(Cannon and Nedergaard, 2004; Collins and Surwit, 2001; Rial
et al., 1983), we testedwhether RAGEplays a role in this pathway
in primary and cultured adipocytes.
Figure 4. Surgical Transplantation of Adipocyte Ager-Deficient iBAT Affects HFD-Induced Metabolic Impairment in WT Mice
(A) Representative photograph of mice surgically transplanted with iBAT from either Agerflox/flox Cre (–) (red, left) or Agerflox/flox Cre (+) iBAT (green, right) after
20 weeks on a HFD.
(B) Body weight curves through 12 weeks on a HFD.
(C) Body composition after 14 weeks of a HFD.
(D–F) Average daily food intake (D), physical activity (E), and energy expenditure (F) were assessed after 16 weeks on a HFD. For (B)–(F), the mean ± SEM is
reported in N = 15 mice/group.
(G and H) Glucose (G) and insulin tolerance (H) tests were performed after 12 or 13 weeks on a HFD, respectively. The mean ± SEM is reported in N = 10–11
mice/group.
(I–M) Thermogenic programs.
(I, K, and M) The relative mRNA expression by qRT-PCR for Ucp1, Dio2, Ppargc1a, Cpt2a, and Pnpla2 for (I) native iBAT, (K) native iWAT, and (M) transplanted
iBAT (tiBAT) retrieved from the WT recipient mice after 20 weeks on a HFD is reported in N = 4–6 mice/group.
(J and L) In (J, native iBAT) and (L, native iWAT), immunohistochemistry for the detection of UCP1was performed and image analysis employed to quantify UCP1-
positive area; representative images are shown at 203 magnification. The mean ± SEM is reported in N = 5 mice/group. Scale bar: 100 mm.
(A–M) Source of donor iBAT: Agerflox/flox Cre (–) shown as red and Agerflox/flox Cre (+) shown as green. Data analysis: (B, G, and H, repeated measures, and C,
independent samples) two-way ANOVA followed by a post hoc Bonferroni test; (D and F–H, area under the curve, and I–M) two-tailed Student’s t test. Where
group mean variances were statistically different (p < 0.05), data were analyzed post hoc using the non-parametric Mann-Whitney U test; *p < 0.05; **p < 0.01,
***p < 0.001, and ****p < 0.0001.
See also Figure S4.
Cell Reports 28, 773–791, July 16, 2019 781
(legend on next page)
782 Cell Reports 28, 773–791, July 16, 2019
We differentiated iBAT- and iWAT-derived adipocytes from
WT and Ager null mice and stimulated them with CL316,243
(CL) (ARB3-specific agonist) to test the effects on lipolysis. In
iBAT adipocytes, significantly higher CL316,243-stimulated
levels of glycerol, and both basal and CL316,243-stimulated
levels of non-esterified fatty acids (NEFAs), were observed in
Ager null than in WT mice (Figure 6A). In iWAT adipocytes, basal
and CL316,243-stimulated glycerol levels were significantly
higher in adipocytes derived from Ager null mice, as was the
CL316,243-mediated stimulation of the NEFA release (Fig-
ure 6B). Significantly higher oxygen consumption rates (OCRs)
were observed in primary iBAT adipocytes from Ager null than
from WT mice after treatment with isoproterenol (non-specific
ARB agonist), which was minimally suppressed by oligomycin
in the Ager null adipocytes, suggestive of maximum mitochon-
dria uncoupling (Figure 6C). When primary iBAT adipocytes
were treated with vehicle or norepinephrine (NE) + T3 (thyroid
hormone), significantly higher Ucp1 mRNA transcripts were
observed in adipocytes devoid of Ager versus WT at baseline
and after NE/T3 (Figure 6D). Primary iBAT-derived adipocytes
from Ager null versus WT mice displayed significantly higher
levels of UCP1 (Figure 6E). These data point to adipocyte-
intrinsic roles for RAGE in b-adrenergic stimulation of lipolysis
and upregulation of Ucp1 expression and activity.
RAGE and its ligand, carboxymethyllysine (CML)-AGE, are
highly expressed in obese human adipose tissue (Gaens et al.,
2014). We previously showed that CML-AGEs were specific
ligands of RAGE (Kislinger et al., 1999). WT primary adipocytes
were treated with vehicle or NE, alone or with CML-AGE. In the
basal state and upon treatment with NE, incubation with CML-
AGE resulted in a significant suppression of Ucp1 and Ppargc1a
mRNA expression in primary adipocytes from iBAT and iWAT
(Figures 6F and 6G). In eWAT-derived adipocytes, CML-AGE
treatment decreased Ucp1 and Ppargc1a at baseline and signif-
icantly suppressed the NE-stimulated induction of Ucp1 with a
similar trend noted for Ppargc1a (Figure S6F). In iBAT-derived
adipocytes, treatment with CML-AGE significantly decreased
the expression of UCP1 (Figure 6H).
To determine if the effects of RAGE ligands were via direct
action on Ucp1 transcription, we employed Ucp1 promoter
luciferase constructs (Figure 6I) transfected into C3H10T1/2
cells. Compared to the vehicle, treatment with NE resulted
in a significant increase in Ucp1 promoter luciferase activity,
which was suppressed by CML-AGE (Figure 6I). We prepared
mutants of the Ucp1 promoter in which only the proximal pro-
moter, which possesses functional CRE-binding elements, or
the enhancer elements, were expressed (Figure 6J). Treat-
ment with CML-AGE exerted only modest effects on the sup-
pression of basal but not NE-mediated promoter luciferase
activities, indicating that the entire Ucp1 promoter was
required to detect the effects of CML on transcriptional activ-
ity. On account of central roles for PKA in the b-adrenergic
stimulation of thermogenic gene programs in adipocytes, we
tested the effects of CML-AGE on PKA activity. In primary
iBAT-derived adipocytes treated with CL316,243 and CML-
AGE, a significant attenuation in PKA activity was observed
(Figure 6K).
RAGE Ligands Suppress Phosphorylation of PKA
Pathway Targets, Phosphorylated Hormone Sensitive
Lipase (pHSL) Ser563 and p38 MAP Kinase, upon b3-
Adrenergic Stimulation
To trace the fate of lipolysis and signaling pathways downstream
of PKA that regulate adaptive thermogenesis, we focused on two
PKA targets: HSL and p38 MAP kinase (MAPK) (Collins, 2012).
Based on the discovery that the cytoplasmic domain of RAGE
is essential for RAGE signaling, in part through its binding to DI-
APH1 (Hudson et al., 2008; Toure´ et al., 2012), we recently
described the small molecule antagonist, 2- [4- (acetylamino)
phenyl] 4- Quinolinecarboxylic acid, methyl ester (‘‘RAGE in-
hibitor’’), which binds to the cytoplasmic domain of RAGE,
blocks its interaction with DIAPH1, and suppresses RAGE
ligand-stimulated signal transduction in cellular and murine
models (Manigrasso et al., 2016). Significantly higher levels of
glycerol release were observed in C3HT101/2 cells treated with
CL316,243 and the RAGE inhibitor (RI) versus CL316,243 alone
(Figure 7A). The RI had no independent effect on the numbers
of lipid droplets, as assessed by staining with BODIPY (Fig-
ure 7B), nor did it affect the relative mitochondrial DNA content
(Figure S7A).
Figure 5. Surgical Transplantation of Adipocyte Ager-Deficient iWAT Affects HFD-Induced Metabolic Impairment in WT Mice
(A) Representative photographs from mice receiving surgical transplantation of either Agerflox/flox Cre (–) (red, left) or Agerflox/flox Cre (+) iWAT (green, right) are
shown after 20 weeks on a HFD.
(B) Body weights through 12 weeks of a HFD.
(C) Body composition after 14 weeks of a HFD.
(D–F) Average daily food intake (D), physical activity (E), and energy expenditure (F) were assessed after 16 weeks of a HFD. In (B)–(F), themean ± SEM is reported
in N = 7–9 mice/group.
(G and H) Glucose (G) and insulin tolerance (H) tests were performed after 12 and 13 weeks of a HFD, respectively. The mean ± SEM is reported in N = 5–6
mice/group.
(I–M) Thermogenic programs.
(I, K, andM) The relativemRNA expression by qRT-PCR forUcp1,Dio2,Ppargc1a,Cpt2a, and Pnpla2mRNA transcripts in (I) native iBAT, (K) native iWAT, and (M)
transplanted iWAT (tiWAT) was examined, and the mean ± SEM is reported in N = 3–4 mice/group.
(J and L) In (J, native iBAT) and (L, native iWAT), immunohistochemistry for detection of UCP1 protein was performed and image analysis employed to quantify
UCP1-positive area; representative images at 203 magnification are shown. The mean ± SEM is reported in N = 5 mice/group. Scale bar: 100 mm.
(A–M) Source of donor iWAT: Agerflox/flox Cre (–) shown as red and Agerflox/flox Cre (+) shown as green. Data analysis: (B, G, and H, repeated measures, and C,
independent samples) two-way ANOVA followed by a post hoc Bonferroni test; (D–H, area under the curve, and I–M) two-tailed Student’s t test. Where group
mean variances were statistically different (p < 0.05), data were analyzed post hoc using the non-parametric Mann-Whitney U test; *p < 0.05; **p < 0.01, ***p <
0.001, and ****p < 0.0001.
See also Figure S5.
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We assessed the effects of RAGE on phosphorylation of HSL
Serine563 and p38 MAPK. Treatment of C3HT101/2 cells with
CL316,243 resulted in significantly higher phospho/total pHSL
Serine563 and phospho/total p38 MAPK compared to vehicle,
which were both significantly reduced by treatment with CML-
AGE. However, in cells treated with CL316,243 and CML-AGE,
treatment with the RI resulted in significantly higher phospho-
p38/total p38 MAPK and trended to higher phospho-HSL
Serine563/total HSL, compared to treatment with CL316,243
and CML-AGE alone (Figure 7C). We hypothesized that if these
effects of RAGE were through a blockade of phosphorylation
of PKA targets, then direct catalytic inhibition of PKA should
blunt the effects of the RI. First, we tested the efficacy of H89,
a commonly used compound to inhibit PKA activity, on the sup-
pression of the effects of CL316,243 (Chijiwa et al., 1990). In
C3HT101/2 cells, treatment with H89 blocked the increased
phosphorylated HSL Serine563/total HSL ratio and the
increased phosphorylated p38/total p38 MAPK induced by
CL316,243 (Figure S7B). We then tested if H89 blocked the
effects of the RI. Compared to cells treated with CL316,243,
CML-AGE, and the RI, the addition of H89 resulted in a signifi-
cant reduction in phosphorylation of both HSL Serine563 and
p38 MAPK (Figure 7D). Thus, direct catalytic inhibition of PKA
blunted the effects of the RI on rescuing the suppressive effects
of CML-AGE on the phosphorylation of pHSL Serine563 and p38
MAPK.
We next tested primary adipocytes from iBAT and iWAT. In
WT, but not in Ager null primary adipocytes derived from
iBAT (Figure 7E) and iWAT (Figure 7F), treatment with CML-
AGE in CL316,243-treated cells resulted in significant suppres-
sion of phosphorylation of pHSL Serine563/total HSL and
p38/total p38 MAPK. In primary iBAT- and iWAT-derived
adipocytes, treatment with CL316,243 resulted in significantly
increased phosphorylated HSL Serine563/total HSL and
increased phosphorylated p38/total p38 MAPK, which was
significantly attenuated by H89 (Figure S7C). Treatment of
Ager null adipocytes from iBAT or iWAT with CL316,243,
CML-AGE, and H89 resulted in significant decreases in phos-
phorylated HSL Serine563/total HSL and phosphorylated
p38/total p38 MAP kinase, compared to cells treated with
CL316,243 and CML-AGE alone (Figures 7G and 7H). Thus,
direct catalytic inhibition of PKA significantly reduced the
effects of deletion of Ager on rescuing the suppression of
CML-AGE on phosphorylation of these two PKA targets. In vivo,
expression of Lipe (gene encoding HSL), a target of activated
PKA (Holm, 2003), was significantly higher in the floating adipo-
cyte fraction retrieved from the iWAT of Ager null than from the
WT mice (Figure S7D).
On account of the demonstrated roles for a PKA-independent,
b3-adrenergic-mediated stimulation of extracellular signal-related
kinase (ERK) MAPK on lipolysis in Robidoux et al. (2006), we
tested the effects of the RAGE ligand, CML-AGE. In C3H10T1/2
cells, treatment with CL316,243 resulted in significantly increased
phospho/total ERK MAPK, which was significantly suppressed
by CML-AGE; the suppressive effects of CML-AGE were pre-
vented by treatment with the RI (Figure S7E). However, in primary
WT orAger null adipocytes retrieved from iBAT or iWAT, no signif-
icant effects of CML-AGE on phospho/total ERK MAPK in
CL316,243-treated cells were observed (Figure S7F).
There were no Ager-dependent differences in the protein
levels of two other lipolytic molecules, adipose triglyceride lipase
ormonoacylglycerol lipase, upon treatment with CL316,243 (Fig-
ures S7G and S7H), and there were no genotype-dependent dif-
ferences in the levels of cyclic AMP (cAMP) between WT and
Ager null CL-316,243-treated primary adipocytes from iBAT,
iWAT, or eWAT (Figure S7I).
Figure 6. RAGE Affects b-Adrenergic-Stimulated Adipocyte Lipolysis and Thermogenic Programming
Primary adipocytes were prepared from the SVF of 8-week-old WT and Ager null mice fed standard chow.
(A andB) iBAT- (A) and iWAT- (B) derived cells were incubated for 3 h in Krebs-Ringer bicarbonate buffer (KRB) and subjected to vehicle or CL316,243 (CL) (10 mM)
for 3 h; glycerol and non-esterified fatty acids (NEFAs) in the media were measured. The means normalized to total protein per well ± SEM are reported from
triplicate, independent experiments from cells derived from N = 5 mice/group.
(C) A representative OCR curve for iBAT-derived adipocytes during a mitochondrial stress test is shown under basal condition and following isoproterenol
(10 mM). This experiment was performed three times using cells derived from N = 3 mice/group per experiment.
(D) Primary iBAT-derived adipocytes from iBAT ofWT orAger null micewere stimulated with norepinephrine (NE; 5 mM) and T3 (thyroid hormone, 2 nM) for 6 h, and
relative Ucp1 mRNA expression was determined by qRT-PCR. The mean ± SEM is reported in N = 4 mice/group.
(E) Western blotting was performed for detection of UCP1/TUBULIN from primary iBAT adipocytes of 8-week-old WT and Ager null mice. The mean ± SEM is
reported in N = 6 independent cell lysates per group along with representative blots.
(F and G) Primary adipocytes from (F) iBAT and (G) iWAT of WT mice were incubated with vehicle or the RAGE ligand CML-AGE (300 mg/ml) for 16 h alone or with
NE (5 mM) for the final 6 h. qRT-PCR for detection of relative Ucp1 or Ppargc1a mRNA expression was performed. The mean ± SEM is reported from N = 5
mice/group.
(H) Cell lysates from primary adipocytes from iBAT of WT mice treated as in (F) and (G) were used for the detection of UCP1/TUBULIN. The mean ± SEM is
reported in cell lysates from N = 3 mice/group.
(I) Schematic of Ucp1 promoter with enhancer elements. Undifferentiated C3H10T1/2 cells were transfected with mouse 3.1 kB Ucp1 promoter luciferase
construct (Ucp1-luc) and stimulated for the last 6 hwith NE (5 mM) and/or CML-AGE (300 mg/ml) for 16 h. Normalized luciferase activities are shown as fold-change
compared to vehicle control.
(J) Ucp1 promoter luciferase constructs were generated and transfected into undifferentiated C3H10T1/2 cells and the cells cultured in medium containing NE
(5 mM) for the last 6 h or CML-AGE (300 mg/ml) for 16 h. Normalized luciferase activities are shown relative to vehicle control. The mean ± SEM of three
independent experiments is presented.
(K) PKA activity was determined in primary iBAT adipocytes fromWTmice treated with CL316,243 (10 mM) for 15min alone or after pre-incubation with the RAGE
ligand CML-AGE (300 mg/ml) for 16 h. The mean ± SEM of N = 8 mice/group is presented.
In (A)–(E), WT (black) and Ager null (green). Data analysis: (A–D, repeated measures) two-way ANOVA followed by post hoc Bonferroni test; (E and H) two-tailed
Student’s t test; (F, G, and I–K) one-way ANOVA followed by a post hoc Tukey’s HSD test; *p < 0.05, **p < 0.01, and ***p < 0.001.
See also Figure S6.
Cell Reports 28, 773–791, July 16, 2019 785
Figure 7. Effects of RAGE Signal Transduction on the PKA Signaling Pathway, Adipocyte Lipolysis, and Phosphorylation of p38 MAP Kinase
(A) Differentiated adipocytes from C3H10T1/2 cells were serum starved for 3 h and pretreated with the RAGE inhibitor (2- [4- (acetylamino) phenyl] 4- Qui-
nolinecarboxylic acid, methyl ester) (1 mM) for 1 h prior to CL316,243 (10 mM) for 15 min. The mean glycerol content normalized to total protein per well ± SEM is
reported from three independent experiments.
(B) C3H10T1/2 cells were differentiated to adipocytes and pre-incubated with a vehicle or the RAGE inhibitor (1mM) for 90 min prior to CL316,243 (10 mM). Lipid
droplets were stained using BODIPY and nuclei stained with DAPI. A representative fluorescence micrograph and mean ± SEM is shown. Scale bar: 100 mm.
(C and D) C3H10T1/2 cells were differentiated and treated with a vehicle or CML-AGE (300 mg/ml) for 75 min alone or after pre-treatment with the RAGE inhibitor
(1 mM) for 30 min followed by CL316,243 (10 mM) treatment for 15 min.
(C) Cells were lysed and western blotting performed for phosphorylated HSL Serine563, total HSL, phosphorylated p38 MAPK, total p38 MAPK, and GAPDH.
(D) Differentiated adipocytes from C3H10T1/2 cells were treated as in (C) with or without the addition of H89 (20 mM) for 30 min prior to CL316,243 (10 mM). Cells
were lysed and western blotting performed for phosphorylated HSL Serine563, total HSL, phosphorylated p38 MAPK, total p38 MAPK, and GAPDH. Band
(legend continued on next page)
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DISCUSSION
The tethering of the biology of molecules implicated in inflamma-
tion to the regulation of metabolism underscores the significance
of these two primal processes to drive and ensure organismal
survival. Here, we demonstrate that the immunoglolubin super-
family molecule, RAGE, suppresses adaptive thermogenesis in
both BAT and WAT, at least in part by reducing the effects of
b-adrenergic signaling in adipocytes, through suppression of
the phosphorylation of PKA targets. In contrast to the suppres-
sive effects of RAGE on metabolic responses, distinct genes
implicated in the inflammatory response positively regulate
adipocyte lipolysis and expression of Ucp1. For example, IRF4
is induced in fasting, and experiments testing adipocyte-specific
deletion of Irf4 (Lee et al., 2013) uncovered its roles in the positive
regulation of adipocyte lipolysis (Eguchi et al., 2011; Kumari
et al., 2016). Further, a role for toll-like receptor 4 (TLR4) in
endotoxin-stimulated regulation of lipolysis in adipocytes was
established (Zu et al., 2009) and shown to be independent of
cAMP-PKA but dependent on the ERK1/2 signal transduction
pathway. The observation that levels of Irf4 and Tlr4 were signif-
icantly higher in adipose tissues of HFD-fed mice bearing adipo-
cyte-specific deletion of Ager versus animals expressing Ager in
adipocytes suggests that RAGE may contribute, directly or indi-
rectly, to the regulation of these genes in adipocytes.
What are the signals that trigger these events in the RAGE
pathway?Many of the families of the RAGE ligands have ‘‘double
lives,’’ in which their intracellular regulatory functions contrast
with unique roles in the extracellular zones as ‘‘damage-associ-
ated molecular pattern (DAMP)’’ molecules (Bertheloot and Latz,
2017; Matzinger, 1994). In the intracellular space, the RAGE
ligands S100/calgranulins and HMGB1 (Taguchi et al., 2000;
Hofmann et al., 1999) modulate calcium homeostasis and are
nonhistone DNA binding proteins, respectively. In the extracel-
lular space, these RAGE ligands assume response-to-stress
functions, such as driving cellular inflammation through activa-
tion of nuclear factor-kB and p38 MAPK (Gunasekaran et al.,
2016; Fujiya et al., 2014). Direct roles for the RAGE ligands in
obesity have been demonstrated, as blocking antibodies to
HMGB1 reduced obesity and inflammation in a mouse model
(Montes et al., 2015). As endogenous RAGE expression in adipo-
cytes may be sufficient to quell thermogenic processes, it is
possible that adipocytes generate and release RAGE ligands,
thereby stringently regulating thermogenesis and energy expen-
diture. Indeed, our data in primary adipocytes from iBAT, iWAT,
and eWAT revealed a time-dependent increase in Ager expres-
sion. In earlier work, ligand expression was linked to transcrip-
tional upregulation of Ager in cultured cells (Li and Schmidt,
1997).
Our data indicate that in states of RAGE ligand enrichment,
such as in high-fat feeding, the activity of the RAGE axis is
heightened. Although iBAT from adipocyte Ager-deleted mice
displays lower levels of Ucp1 and Dio2 at room temperature
and in low-fat feeding (i.e., LOW RAGE LIGAND environment)
when compared to iBAT from adipocyte Ager-expressing mice
(Figure 3J), when these iBAT tissues are transplanted into envi-
ronmentally-stressed WT mice fed a HFD (i.e, HIGH RAGE
LIGAND environment), the absence of RAGE in adipocytes unre-
strains thermogenic programming, as evidenced by the
increased expression of Ucp1, Dio2, Ppargc1a, Cpt2a, and
Pnpla2 mRNA in the transplanted iBAT of the adipocyte Ager-
deleted versusAger-expressing iBAT (Figure 4M). These consid-
erations are supported by the work presented in Figures 6 and 7,
in which the RAGE ligand CML-AGE suppresses lipolysis, phos-
phorylation of p38 MAPK, and thermogenic gene programs.
The activation of the b3-adrenergic receptor, which is highly
expressed in adipocytes, results in the generation of cAMP
and consequent PKA-mediated phosphorylation of HSL and
perilipin (Soeder et al., 1999). The present studies illustrate that
recently identified inhibitors of RAGE signal transduction (Mani-
grasso et al., 2016) block the RAGE ligand-mediated reduction of
phosphorylation of PKA targets in adipocytes. Ager deletion, un-
like the metabolic braking effects of KCNK3 (Chen et al., 2017),
exerted no effects on cAMP levels in adipocytes at baseline
or after CL316,243 stimulation. The observation that catalytic
inhibition of PKA (H89) effectively blocked the effects of Ager
deletion or the effects of the RI on adaptive thermogenesis in pri-
mary and cultured adipocytes supports a notion that the RAGE
effects are mediated, at least in part, through the suppression
of PKA-dependent phosphorylation of its downstream targets
in adipocytes. In line with recent work that demonstrated that
lipolysis in BAT is not required for cold-induced thermogenesis
(Schreiber et al., 2017; Shin et al., 2017), our findings reveal
broader effects for RAGE, in that beyond RAGE-dependent sup-
pression of the b-adrenergic-mediated phosphorylation of PKA
target HSL in adipocytes, fundamental signaling pathways that
regulate Ucp1 and thermogenic genes, such as phosphorylation
of p38 MAPK, are also downregulated by RAGE ligands and
restored by Ager deletion or by treatment with RIs.
The present findings trace the impact of Ager deletion in the
regulation of adaptive thermogenesis from the induction of lipol-
ysis, particularly through the phosphorylation of HSL, to the gen-
eration of glycerol and free fatty acids and to the phosphorylation
of p38 MAPK and regulation of Ucp1 mRNA transcription. It is
intensities were normalized to the respective total HSL or total p38 MAPK, and the relative fold change is presented as mean ± SEM. Each experiment consisted
of at least three independent studies with at least three technical replicates.
(E–H) Primary adipocytes from (E and G) iBAT or (F and H) iWAT of WT and Ager null mice were treated with the RAGE ligand CML-AGE (300 mg/ml) for 1 h,
CL316,243 (10 mM) for 15 min, and with or without H89 (20 mM) for 30 min prior to CL. Cells were lysed and western blotting performed for the detection of
phosphorylated HSL Serine563, total HSL, phosphorylated p38 MAPK, total p38 MAPK, and GAPDH. Band intensities were normalized to the respective total
HSL or p38 MAPK, and the relative fold change is presented as mean ± SEM from N = 4 pooled mice/group in three independent experiments with at least 2–3
technical replicates per experiment.
Data analysis: (A–H) one-way ANOVA followed by a post hoc Tukey’s HSD test or Bonferroni test, as indicated; *p < 0.05; **p < 0.01, ***p < 0.001, and
****p < 0.0001.
See also Figure S7.
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established that circulating fatty acids from lipolysis serve as key
cofactors facilitating the activation of UCP1 and the transport of
protons across mitochondrial membranes, which is essential for
mammalian regulation of heat (Garlid et al., 1996; Klingenberg
and Winkler, 1985; Cannon and Nedergaard, 2004). In contrast
to the suppressive effects of RAGE signaling on phosphorylation
of p38 MAPK in primary adipocytes (iBAT and iWAT) and in
C3H10T1/2 cells, our experiments revealed inconsistent findings
regarding phosphorylation of ERK. Although the reasons for the
differences in ERK MAPK phosphorylation vis-a`-vis RAGE be-
tween cell lines and primary adipocytes remain to be identified,
our data nevertheless point to clear roles for RAGE signaling-
dependent regulation of HSL and p38 MAPK phosphorylation
downstream of PKA.
In the broader context of evolution and adaptive selection,
then, what forces drive this metabolic braking role for Ager?
Selective pressures in evolution favor phenotypes that safeguard
survival in the face of paucities and extreme stresses (Hotamisli-
gil, 2017). Hence, when nutrient supplies are unlimited and
selective survival pressures are lost, the urge to hoard energy,
if unchecked, may become a vulnerability. The gene AGER,
located on chromosome 6 in the major histocompatibility
complex (MHC) III humans (Wu et al., 2015), first appeared in
Laurasiatheria (Sessa et al., 2014), a superorder of placental
mammals that is part of the larger group of mammals classified
as Eutheria. Eutheria are mammalian clades, and the oldest
Eutherian species is believed to be Juramaia sinensis, which
dates to 160 million years ago (mya) (Gerkema et al., 2013). A
key property of the Eutherians is the expression of UCP1 in
BAT, which imbues the capacity for non-shivering thermogene-
sis (Hughes et al., 2009). Mammals first appeared during the
Mesozoic era, about 250 mya, which followed the period known
as the ‘‘Great Dying,’’ in which amassive extinction of plants and
land species ensued consequent to a period of intense global
warming (Gerkema et al., 2013; Sun et al., 2012). Perhaps
AGER evolved as a defense against starvation or swings in
ambient temperatures through its ability to suppress adaptive
thermogenesis.
These premises may indeed be consistent with hypotheses
that reduced energy expenditure and obesity may be the unin-
tended consequences of evolutionary pressures against severe
starvation (‘‘thrifty genotype’’) (Neel, 1962; Prentice, 2005;
Wang et al., 2014) or the need to protect from extreme temper-
ature swings throughout human migration (Sellayah et al.,
2014). At thermoneutrality, mice devoid of Ager bear body tem-
peratures that are indistinguishable from those of WT animals,
thereby implying that RAGE-dependent forces are not triggered
during homeostasis, but are evoked under stress conditions in
which the ligands of the receptor accumulate. Indeed, in the
evolution of AGER, the major adaptively selected sites within
the protein product RAGE are within the extracellular ligand
binding domains, the intracellular adaptor binding regions, and
the surfaces facilitating oligomerization and, thereby, signal
transduction (Wu et al., 2015).
Notably, distinct pathways linking metabolism and inflamma-
tion, specifically TLR, insulin receptor, and tumor necrosis factor
(TNF) receptor signaling, may be traced to orthologs in
Drosophila (Hotamisligil, 2017). This is not the case for Ager.
However, the RAGE ligands HMGB1 and S100/calgranulins,
such as S100A8/A9, may also bind TLRs (Gunasekaran et al.,
2016; Hiratsuka et al., 2008). TLRs play innate roles in host
defense, but the role of Ager in response to infectious pathogens
is assuredly more complex (van Zoelen et al., 2011). Whereas
in cecal ligation and puncture (sepsis) or in Streptococcus
pneumonia pneumonia, a deficiency of Ager in mice improved
survival (Liliensiek et al., 2004; van Zoelen et al., 2009), the loss
of Ager in Klebsiella pneumoniae pneumonia was detrimental
(Achouiti et al., 2016). Together with the marked differences in
appearance of TLR versus AGER in evolution and the lack of
consistent roles for AGER in innate host defense to pathogens,
it is plausible that RAGE’s ability to conserve energy under-
scores its primal endogenous function, which evolved, remark-
ably, at the expense of unremitting and chronic inflammation
and the dampening of tissue repair on account of RAGE’s ability
to usurp the functions of HMGB1 and S100/calgranulins ligands.
Such a scenario frames a critical paradigm in the immunometa-
bolic nexus of genes that integrate inflammatory and metabolic
responses and identifies RAGE as an innate mechanism in the
suppression of adipocyte metabolism and energy expenditure.
In summary, this work demonstrates that RAGE suppresses
adaptive thermogenesis in both BAT and WAT during a physio-
logical response to fasting, a cold challenge, or high-fat feeding;
adds Ager to the cadre of genes that tether inflammation to the
regulation of energy homeostasis; defines the endogenous func-
tion of RAGE in energy metabolism; and pinpoints tractable ther-
apeutic targets to harness energy expenditure in metabolic dis-
orders through the blockade of RAGE signal transduction.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Anti-UCP-1 (Western Blot) Abcam Cat# ab10983; RRID:AB_2241462
Anti-UCP-1 (Immunohistochemistry) Abcam Cat# Ab23841; RRID:AB_2213764
Anti-phospho HSL (Ser563) Cell Signaling Cat# 4139S; RRID:AB_2135495
Anti-total HSL Cell Signaling Cat# 4107S; RRID:AB_2296900
Anti-Tubulin Cell Signaling Cat# 3873S; RRID:AB_1904178
Anti-phospho ERK Cell Signaling Cat# 9101L; RRID:AB_331646
Anti-total ERK Cell Signaling Cat # 9102; RRID:AB_330744
Anti-ATGL Cell Signaling Cat # 2439S; RRID:AB_2167953
Phospho-p38 MAPK (Thr180/Tyr182) Cell Signaling Cat #9211; RRID:AB_331641
Anti-p38 MAPK Cell Signaling Cat # 9212; RRID:AB_330713
Anti-Beta Actin Santa Cruz Cat# sc-81178; RRID:AB_2223230
Anti-Monoacylglycerol Lipase (MGL) Abcam Cat# ab180016
IRDye 680RD goat anti–mouse IgG Li-Cor Cat# 925-68070; RRID:AB_2651128
Dylight 800-conjugated goat anti–mouse IgG Li-Cor Cat# 925-32211; RRID:AB_2651127
Anti-GAPDH Santa Cruz Cat# sc-47724; RRID:AB_627678
Chemicals, Peptides, and Recombinant Proteins
Hoeschst 33342 Invitrogen H3570
Seahorse XF Cell Mito Stress Test Agilent 103015-100
Seahorse XFe24 FluxPak Agilent 100850-001
iScript cDNA Synthesis Kit, 500 3 20 ml rxns Biorad 1708891BUN
10x Tris/Glycine Buffer Bio-Rad 1610771EDU
10x Tris/Glycine/SDS Bio-Rad 1610732EDU
4–15% Mini-PROTEAN TGX Precast Protein Gel Bio-Rad 4561086
Cell Lysis Buffer (10X) Cell Signaling 9803
RIPA Buffer (10X) Cell Signaling 9806
4-20% Mini-PROTEAN TGX gels Bio-Rad 456-1096
Trans-Blot Turbo Midi Nitrocellulose Transfer Bio-Rad 1704159
10x Tris/Glycine/SDS Buffer Bio-Rad 161-0772
10x Tris/Glycine Buffer Bio-Rad 161-0771
Sybr Green Applied Biosystems 4385618
Odyssey Blocking Buffer (PBS) Li-Cor 927-40003
MitoTracker Red CMXRos Life Technologies M7512
DMEM, high glucose, HEPES, no phenol red Life Technologies 21063-029
Phusion High-Fidelity PCR Kit New England Biolabs, Inc E0553L
Dual-Glo Luciferase Assay System Promega E2940
Glo Lysis Buffer, 1X Promega E2661
QIAzol Lysis Reagent QIAGEN 7906
RNeasy Mini Kit (250) QIAGEN 79306
Paraformaldehyde solution 4% in PBS Santa Cruz Biotechnology CAS 30525-89-4
()-Norepinephrine Sigma A7257
3,30,5-Triiodo-L-thyronine sodium salt Sigma T6397
3-Isobutyl-1-methylxanthine Sigma I5879
CL 316243, Sigma C5976
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Collagenase from Clostridium histolyticum Sigma C6885-1G
Dexamethasone Sigma D4902
Free Glycerol Reagent Sigma F6428
Glucose Sigma G8270
Glycerol Standard Sigma G1394
H-89 dihydrochloride hydrate Sigma B1427-5MG
Insulin from bovine pancreas Sigma I6634
Isoproterenol Sigma I5627
Rosiglitazone Sigma R2408
DMEM ThermoFisher Scientific 11995065
Lipofectamine 3000 Transfection Reagent ThermoFisher Scientific L3000001
Optimem ThermoFisher Scientific 31985047
Bovine Serum Albumin - Fatty Acid Free Roche 3117057001
FBS Corning 35-010-CV
Glucose strips - FreeStyle Lite Blood Glucose Test Strips Abbott 70819-70
D-Glucose Alfa Aesar A16828
Magnesium Chloride Sigma M8266
Sodium Chloride Fisher Scientific BP318-212
Potassium Chloride Fisher Scientific P217-500
Sodium Phosphate Dibasic Sigma S3264
LipidTox ThermoFisher Reagent H34476
BODIPY ThermoFisher Reagent D3922
DAPI Life Technologies D1306
Sodium Phosphate Monobasic Sigma S8282
Sodium Bicarbonate Fisher Scientific S3233-500
Insulin (Human) - Humulin R Lilly 0002-8215-01
CML-AGE Synthesized in Laboratory per
Kislinger et al., 1999
N/A
2- [4- (acetylamino) phenyl] 4- Quinolinecarboxylic
acid, methyl ester
Synthesized Per the Methods/Source
outlined in Manigrasso et al., 2016
N/A
Critical Commercial Assays
2-CAT (A-N) Research ELISA Rocky Mountain Diagnostics BA E-5400
cAMP Direct Immunoassay Kit Abcam Ab65355
Glycerol/Triglyceride Determination Kit Sigma TR0100-1KT
NEFA HR(2) color reagent A Wako Diagnostics 99934691
NEFA-HR(2) color reagent B Wako Diagnostics 99134891
NEFA HR(2) Solvent A Wako Diagnostics 99534791
NEFA HR(2) Solvent B Wako Diagnostics 99335191
cAMP Assay Kit Abcam ab65355
Pierce BCA Protein Assay Kit ThermoFisher 23225
PKA Kinase Activity Assay Kit Abcam ab139435
Experimental Models: Cell Lines
C3H/10T1/2, Clone 8 (ATCC CCL-226) ATCC American Type Culture Collection ATCC CCL-226
Experimental Models: Organisms/Strains
C57BL/6J mice Jackson Laboratory JAX:000664
Ager Flox/ Flox mice N/A N/A
Adipoq Cre Recombinase mice Jackson Laboratory 28020
Ager null mice N/A N/A
(Continued on next page)
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LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and request for resources and reagents should be directed to the lead Contact Ann Marie Schmidt (AnnMarie.
Schmidt@nyulangone.org).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mouse Strains
All animal procedureswere approved by theNewYork University, University ofMassachusettsMedical School and Sanford Burnham
Institute (Lake Nona, Orlando FLA) Institutional Animal Care and Use Committees and performed in accordance with the National
Institutes of Health Animal Care Guidelines. Homozygous Ager null mice (Liliensiek et al., 2004) (C57BL/6 Ager null mice back-
crossed > 20 generations into C57BL/6J [The Jackson Laboratory, Bar Harbor, ME]) and their littermate Ager-expressing controls
or C57BL/6J were used. In order to generate adipocyte-specific Ager-deleted mice, we developed a floxed mouse line, suitable
for the generation of a conditional deletion model for the Ager gene (GenOway, Lyon, France). Agerflox/flox mice were bred with
Adiponectin (Adipoq) Cre-recombinase mice to yield Agerflox/flox Adipoq Cre (+) and Agerflox/flox Adipoq Cre (–) littermate mice,
resulting in deletion of Ager from both white and brown adipose tissue depots. Adiponectin Cre-recombinase were obtained from
the Jackson Laboratory (Stock No: 028020), which were in the C57BL/6J background. C57BL/6J (WT) mice were obtained from
The Jackson Laboratory (Stock No: 00664). All mice studied were male, had free access to food and water, unless otherwise noted
in specific fasting/refeeding or fasting state studies, andwere subjected to 12 h light/dark cycles.Micewere bred, born and housed in
a pathogen-free barrier environment, which was negative for Helicobacter or Norovirus pathogens. Mice were housed in standard
caging up to 4 mice per cage and, where, indicated, were single housed for the indicated periods of time in order to perform specific
studies such as indirect calorimetry and measurement of food intake that required the presence of only one mouse per cage. At
4–5 weeks of age, mice were anesthetized with 1% isoflurane, and tail snips were analyzed by PCR. To confirm adipose-specific
deletion of Ager, fat depots (eWAT, iWAT, and iBAT) from offspring were isolated and purification of total genomic DNA (gDNA)
was performed according to the manufacturer’s instructions (DNeasy Blood and Tissue, QIAGEN). Thereafter, gDNA was subjected
to PCR analysis using primers spanning the deletion site (exon 6) in the Ager gene (GenBank Accession number NM_007425.3)
forward: 50-GGTACCCTGCACCCAACTAC-30 and reverse: 50-TTGATGGCCCTGGGATTGAC-30). The following conditions with Plat-
inum TM taq DNA polymerase from Invitrogen were used for PCR: 95C for 30 s, 58C for 30 s, and 72C for 1 min (29 cycles). The
resulting PCR products were separated using agarose gel electrophoresis, and the bands were visualized. The primary data
illustrating the targeting vector construct and the characterization of these mice are shown in Figures S3A–S3C. In all cases, within
genotypes, mice were randomly assigned to study groups upon review of a database, which indicates mouse date of birth, sex,
identification number and body weight. Randomization and study group assignment was performed with the assistance of technical
support staff in the laboratory who were not involved in the design or protocol of the specific experiments.
Cells Used in the Study
C3H10T1/2 cells, purchased from ATCC (Manassas, VA), catalog number ATCC CCL-226, were plated at low density and cultured in
DMEM containing 10% (vol/vol) FBS and 1% (vol/vol) penicillin-streptomycin. Two days post-confluence (designated day 0), cells
were induced to differentiate with DMEM containing 10% (vol/vol) FBS, 1mg/ml insulin, 2 nM T3, 0.5 mM isobutylmethylxanthine,
1 mM dexamethasone and 1 mM Rosiglitazone until day 2-5. After this induction phase, complete medium was supplemented with
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Recombinant DNA
pGL3- UCP1 Koza Laboratory N/A
PGL3 Basic Promega E1741
Software and Algorithms
Graphpad Prism 8.02 GraphPad Software https://www.graphpad.com
Leica Digital Image Hub Leica Biosystems https://www.leicabiosystems.com
ImageJ NIH https://imagej.nih.gov
Fiji (distribution of ImageJ) Schindelin et al., 2012 https://fiji.sc
WAVE Seahorse XFe24 Analyzer Agilent https://www.agilent.com
LI-COR Odyssey Classic Li-Cor https://www.licor.com
Trans-Blot Turbo Transfer System Bio-Rad http://www.bio-rad.com
Image Studio Lite Li-Cor https://www.licor.com
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insulin and T3 until day 8. Before any treatment, cells were starved for 3 h in 2% fatty acid free Krebs-Ringer bicarbonate (KRB) buffer.
For treatments to stimulate RAGE, CML-AGE, 300 mg/ml, was added to the media for the indicated time periods.
Primary adipocytes were derived from eWAT, iWAT and iBAT of male mice from the lines of animals described above. Fat depots
were retrieved and immediately washed with PBS, minced and digested with collagenase type II (1 mg/ml), 45 mins, 37C) in DMEM
containing 1% (wt/vol) BSA. Digested tissues were filtered through sterile 100 and 40 mm cell strainers and centrifuged (2000 rpm,
10 min). The floating fractions containing adipocytes were separated from the SVF and stored at 80C with QIAzol (QIAgen) until
further analysis. The cells were centrifuged at 2000 rpm for 5 mins, plated on a 12-well culture dish, and grown and differentiated
to mature adipocytes. Briefly, cells were grown to confluence in DMEM, 10% (vol/vol) FBS and 1% (vol/vol) penicillin-streptomycin
followed by standard adipogenic induction (1mg/ml insulin, 2 nM T3, 0.5 mM isobutylmethylxanthine, 1 mMdexamethasone, and 1uM
rosiglitazone). After 2-5 days induction phase, complete medium was supplemented with insulin and T3, until day 8. Before any
treatment, cells were serum-starved for 1-3 h in either DMEM or KRB buffer containing 2% fatty acid free BSA.
METHOD DETAILS
Fasting experiments
Fasting and feeding studies were performed in mice fed a standard chow diet (5053 PicoLab Rodent Diet 20; LabDiet, Brentwood,
MO). To determine the effect of nutritional status, 11-week-old male Ager null mice andWTmice were fed ad libitum, fasted for 24 h,
or re-fed for 24 h after the 24 h fast.
Cold-induced thermogenesis and thermoneutrality studies
Cold-induced thermogenesis over 48 h was assessed at the Cardiometabolic Phenotyping Core of the Sanford Burnham Institute
(Lake Nona, Orlando FL) where Ager null mice and WT mice were individually housed in home cages with ad libitum access to
food and water. The cages were placed in an environmentally-controlled chamber (Powers Scientific, Inc.) with the temperature
set at 23C (standard housing temperature). The temperature was then gradually lowered to 4C over a span of6 h. Mice remained
in the chamber at 4C for 48 h. During this 48 h period, core body temperature was measured three times per day (10:00, 14:00 and
17:00) using a rectal probe attached to a digital thermometer. Short-term cold exposure (4C for 24 h) thermogenesis studies were
carried out at NYU Medical Center. Ager null, WT, Agerflox/flox Adipoq Cre (+) and Agerflox/flox Adipoq Cre (–) male mice 8 weeks old
were exposed to 4C for 24 h. Core body temperature was measured every 6 h using a rectal probe (ThermoWorks, Alpine UT). For
thermoneutrality studies, male Ager null and WT mice, 8 weeks of age, were housed at 30C for 24 h in individual cages. Core body
temperature was measured every 6 h using a rectal probe (ThermoWorks, Alpine UT). At 24 h, mice were removed and immediately
euthanized for tissue collection.
Diet-induced obesity and indirect calorimetry
For HFD studies Agerflox/flox Adipoq Cre (+) and Agerflox/flox Adipoq Cre (–) were fed a HFD with 60% of calories from lard (D12492;
Research Diets, Inc., New Brunswick, NJ) or low-fat diet (LFD) with 13% of calories from fat (5053 PicoLab Rodent Diet 20; LabDiet,
Brentwood, MO). Metabolic studies in Agerflox/flox Adipoq Cre (+) and (-) mice were performed at the National Mouse Metabolic
Phenotyping Center (MMPC) at UMass Medical School (Worcester, MA) and metabolic studies in mice surgically transplanted
with adipose were performed at NYU Medical Center. Metabolic cages (TSE Systems, Inc., Midland, MI) were used in conscious
mice to simultaneously measure energy expenditure through indirect calorimetry analyses, food/water intake, and physical activity
at before (baseline at 8 weeks of age) and after the indicated periods of HFD (Dagdeviren et al., 2016; Lee et al., 2015a).
Dual Energy X-Ray (DEXA) Absorptiometry
DEXA scans were employed to determine body composition. Before each scan session, the instrument was calibrated as per the
manufacturer’s direction. Mice were then weighed, briefly anesthetized via isoflurane inhalation and placed on a scanning area of
a Lunar PIXImus DEXA instrument (PIXImus, WI). Mice remained immobilized on this surface for the duration of the entire scan. At
least 3 scans per mouse were performed and the average lean and fat mass were recorded.
Soluble (s) RAGE
Soluble RAGE (sRAGE) (human) was prepared, purified, and rendered free of endotoxin as previously described (Park et al., 1998)
and 100 mg/day by intraperitoneal (IP) route was administered to mice beginning immediately at the time of HFD feeding at age
6 weeks. Control mice were treated with equal amounts of vehicle PBS.
Glucose and Insulin Tolerance Tests
Glucose (GTT) and insulin tolerance tests (ITT) were performed onmice after fasting for 5-6 h and acclimated to the testing roomwith
access to water. Mice were injected intraperitoneally (IP) with either D-glucose (Sigma, 0.75-1.5 g per kg of body weight) or recom-
binant human regular insulin (0.5-1 U per kg of body weight); blood glucose levels were measured via tail sampling after fasting for a
baseline measurement (t = 0) and again at t = 15, 30, 60, 90 and 120 mins post glucose or insulin bolus using a glucometer (Freestyle
Freedom Line, Abbott Diabetes Care Inc, Alameda CA).
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iBAT and iWAT transplantation
Following standard antiseptic surgical techniques, iBAT transplantation in the subcutaneous dorsal region was performed as
described (Stanford et al., 2013) with the following modifications. iBAT pads were removed from 6-week old Agerflox/flox Adipoq
Cre (+) and Agerflox/flox Adipoq Cre (–) male mice and transplanted into 6-week old WT recipient male mice. Specifically, after eutha-
nasia of donor mice, bilateral iBAT was immediately excised, peripheral white fat was removed, and the remaining iBAT (90 mg)
washed in sterile PBS and transplanted into the subcutaneous anterior dorsal region of recipient mice as quickly as possible.
With the same approach, bilateral iWAT (250mg) from twoAgerflox/floxAdipoq Cre (+) orAgerflox/floxAdipoq Cre (–) donors was trans-
planted to a single recipient (2:1 donor:recipient) bilaterally into the posterior dorsal region of the recipient through small incisions of
2-3 mm in length beginning at the proximal end of the hind limb (Tran et al., 2008). Recipient mice were anesthetized with gas iso-
flurane and treated with buprenorphine during and after surgery for pain relief, mice were then monitored until recovered. In both
cases, after 4 days of recovery from surgery, mice were fed a 60% HFD for the time course, as indicated in the figures. Mice
were housed 4-5 per cage.
Protein extraction and western blot analysis
Protein was extracted from cells and tissue from eWAT, iWAT and iBAT or other cell or tissue lysates as indicated by using lysis buffer
or RIPA (Cell Signaling) supplemented with complete protease inhibitor cocktail (Roche), and centrifuged at 13,000 g for 15 mins at
4C. The supernatant was collected and protein concentration was measured using a bicinchoninic acid (BCA) protein quantification
kit (Thermo Scientific, Waltham, MA). Samples were diluted to one constant protein concentration followed by addition of sample
reducing agent and loading dye (Thermo Scientific, Waltham, MA). For western blot analyses, 20-50 mg of protein were separated
in 4%–20% Mini-PROTEAN TGX gels (Bio-Rad, Hercules, CA) and blotted onto nitrocellulose membranes (Bio-Rad, Hercules,
CA). Membranes were blocked at room temperature for 1 h with Odyssey LI-COR Blocking Buffer (LI-COR, Lincoln, NE) diluted
1:1 in Tris-buffered saline (TBS). Membranes were then incubated with primary antibodies (diluted 1:1000 in a 1:1 Blocking
Buffer/TBS-T solution) overnight at 4C. Primary antibodies detailed in the STARmethods key resource table were used. Membranes
were washed consecutively 3 times for at least 5 mins each in TBS-T (0.1%). Blots were incubated with IRDye 680RD goat anti–
mouse IgG and IRDye 800CW goat anti–rabbit IgG (LI-COR, Lincoln, NE) for 1 h at room temperature in blocking buffer containing
0.1% TBS-T and 0.1% SDS. Blots were washed 3 more times in TBS-T followed by a final wash in TBS, the blots were scanned with
the LI-COR Odyssey Classic (LI-COR, Lincoln, NE) and quantified with Image Studio Lite software (LI-COR, Lincoln, NE) based on
direct fluorescence measurement.
RNA analysis and Real-time quantitative PCR
Total RNA was extracted from cells and tissue samples using TRIzol and RNeasy kits (QIAGEN) followed by cDNA synthesis using
iScript Reverse Transcription Supermix for RT-PCR (Bio-Rad). qPCR was performed using the TaqMan method (50C for 2 mins,
95C for 10 mins, and 40 cycles of 95C for 15 s and 60C for 1 min) with premade primer sets (Applied Biosystems). The relative
abundance of transcripts was normalized according to the expression of Actb using the DDCt method. Primer sequences are listed
in Table S1.
Mitochondrial DNA content
Genomic DNA was isolated from C3H10T1/2 cells using the DNeasy Blood & Tissue Kit (QIAGEN) following manufacturer’s
instructions. Quantitative real-time PCR assessed genomic expression of mitochondrial NADH dehydrogenase subunit 1 (Nd1)
Fwd 50 GGCCACATGGCTACCATTTG 30 and Rev 50 CCGACCACTCACATTCACC 30 normalized to Hbb (b-globin) Fwd 50
ACACAAGGGACAAGAGGAATCC 30 and Rev 50 GGGTCAGGTCTTTGCTTCCA 30 in genomic extracts from adipocytes differentiated
from C3H10T1/2 cells treated with vehicle or CL316243 (Sigma) with or without the small molecule RAGE inhibitor (RI); 2- [4- (ace-
tylamino) phenyl] 4- Quinolinecarboxylic acid, methyl ester. MitoTracker Red CMXRos (Thermofisher) (75nM) was used to check
the function of mitochondria in live iBAT-derived primary adipocytes fromWT andAger null mice at 37C for 30 min to stain functional
mitochondria, according to manufacturer’s protocol.
XF24 Extracellular Flux Analysis (Seahorse)
SVF cells isolated from the indicated adipose tissue depots from WT and Ager null mice were seeded in 24-well Seahorse plates and
differentiated, as described above. The oxygen consumption rate (OCR) of 8 days differentiated cells was determined with an XF24
Extracellular Flux Analyzer (Seahorse Bioscience, Proteigene, Saint Marcel, France). Isoproterenol (10 mM) was used to characterize
b-adrenergic inducible respiration and injected before oligomycinwas indicated. Uncoupled andmaximumOCRwere determinedwith
oligomycin (1 mM) and FCCP (1.5 mM). Rotenone (1 mM) and antimycin A (1 mM)were used to inhibit complex I- and III-dependent respi-
ration, respectively. OCR was determined by plotting the oxygen tension and acidification of the medium in the chamber as a function
of time and normalized by protein concentration (picomoles permin permilligram), respectively, as per themanufacturer’s instructions.
Assessment of Lipolysis
Differentiated adipocytes from iWAT or iBAT or differentiated C3H10T1/2 cells were starved for 3 h. Fresh medium (DMEM without
Red Phenol) with 1% fatty acid free-BSAwas added and the cells were immediately subjected to the indicated treatment (CL316243)
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for the indicated times. Sampled medium was used to measure glycerol release with a free glycerol reagent (Sigma Aldrich), accord-
ing to themanufacturer’s instructions. Results were normalized to total sample protein content. For free fatty acid measurement, fully
differentiated iWAT and iBAT-derived primary adipocytes were starved for the indicated times in KRB buffer containing 2% fatty acid
free BSA (Roche) followed by treatment with either vehicle or CL316243 (SigmaAldrich). Media and cell sampleswere collected at the
indicated times and stored at 80C until analyzed. Non-esterified free fatty acids (NEFA) from media were measured using a
colormetric NEFA assay (WAKO) per the manufacturer’s protocol and normalized to total sample protein content.
Cell transfection and reporter assay
Undifferentiated C3H10T1/2 cells, clone 8 (ATCC CCL-226) were transfected with pGL3 (Addgene) or complete Ucp1 promoter
luciferase reporter constructs (generously shared by Dr. R. Koza) and 220-bp BAT-specific enhancer and proximal promoter of
the mouse Ucp1 gene obtained by PCR amplification as described (Rim and Kozak, 2002) using lipofectamine 3000 (Thermofisher).
At 24 h after transfection, cells were stimulated with NE (5 mM) and CML-AGE (300 mg/ml) as indicated. Cell lysates were harvested
48 h after transfection, and luciferase activity was quantified by standard luminometer assay and normalized to Renilla signal (Renilla
Luciferase Assay System, PROMEGA).
Measurement of cAMP levels
Differentiated adipocytes from iBAT iWAT and eWAT fromWT and Ager null mice were grown with complete medium supplemented
with insulin and T3. At day 7 of differentiation, complete medium was replaced with DMEM + 0.2% BSA for 16 h. The cells were then
treated with serum free DMEN ± 10 mM CL316,243 for 10 mins. Cells were collected, lysed, and intracellular cAMP levels were
measured with cAMP Assay Kit (Competitive ELISA) (ab65355). cAMP levels were normalized to protein content.
Protein Kinase A Activity Assay
Differentiated primary brown adipocytes fromWTmice were treated overnight with vehicle or RAGE ligand, CML-AGE (300 mmg/ml)
followed by stimulation with CL316,243 for 15 mins. Cells were washed twice with RIPA buffer. Fifteen mg of cell lysate protein were
used for the kinase reaction according to the manufacturer’s instructions (Enzo Life Science, NY). For the negative control, only the
RIPA buffer was used in the reaction mixture. Data were normalized to total protein content.
Histology and Immunohistochemistry
For staining of adipose tissue for UCP1 antigen, iBAT, iWAT and eWAT samples were dissected and fixed in 4% paraformaldehyde
(PFA) overnight or up to 48 h at 4C. Samples were then washed at least three times in PBS and processed for paraffin embedding.
Embedded blocks were sectioned at 5 mm thickness and placed onto histology slides. Slides were deparaffinized (Leica AR9222
dewax) and stained on a Leica BondRX autostainer. Prior to the incubation with the primary antibody, sections underwent
heat retrieval with Bond Epitope Retrieval Buffer 2 (Leica ER2, AR9640), and incubation with hydrogen peroxidase to eliminate
endogenous peroxidase activity. To achieve an appropriate range of staining with different sample subsets, the primary antibody,
UCP1 (Abcam ab23841) was diluted ((Leica diluent, ARD1001EA) 1:100 and 1:500 for iWAT and iBAT, respectively) and stained
for 12 h. Sectionswere subsequently incubatedwith Leica anti-rabbit polymer conjugated to horse radish peroxidase (DABKIT, Leica
DS9800) and developed with diaminobenzidine. After counterstaining with hematoxylin, the sections were imaged on a Leica
SCN400 whole slide scanner up to 40x magnification. Using the Slidepath Digital Imaging Hub software (Leica Biosystems),
3 randomly-selected section images per animal were captured at 20x magnification and used for quantification of UCP1 by an
experimenter naive to the identification of the experimental groups.
Immunofluorescence microscopy
C3H/10T1/2 cells or SVF-derived adipocytes isolated either from WT or Ager null mice were grown on coverslips to obtain fully
differentiated primary adipocytes. Cells were fixed with 4% PFA for 20 mins. After 5 mins of Triton X-100 0.2% permeabilization
and 15 mins of blocking (PBS-BSA 3%), lipid droplets were stained using BODIPY or LipidTox for the indicated times. After washing
10 times with 1x PBS, cells were incubated with DAPI (Life Technologies) for 5 mins at room temperature. Cells were then washed
extensively with 1x PBS and mounted on glass slides with Prolong-Gold (Life Technologies). All gains for the acquisition of compa-
rable images were maintained constant and the Leica 5500B microscope was used to capture the images. Analysis of the images
was performed using ImageJ (NIH) and Adobe Photoshop CC 2015.
Image analysis and quantification
MacBiophotonics ImageJ was used for image quantification and analysis of LipidTOX/BODIPY staining. To quantify the staining of
lipid droplets with LipidTOX/BODIPY, the immunofluorescence of this dye was recorded as a digital, 8-bit gray-scale, 1024x1024
resolution images. The lipid droplet labeling image threshold was set at 90 on a 0–255 black to white scale (all pixels with a value
under 90 were excluded from the quantification) to remove background pixels from measurement. The number of individual cells
in every image was counted by DAPI staining. Quantification of LipidTOX/BODIPY staining in each condition is represented as
mean intensity value divided by number of nuclei.
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The Fiji distribution of ImageJ was used for image quantification and analysis of UCP1 immunostaining. To quantify the area of
UCP1 staining, the images were first de-convoluted to separate the DAB (3,30-diaminobenzidine) stain from the hematoxylin
counter-stain using the Fiji plug-in Color De-convolution 1.7 (vector-H DAB). The resulting image was then subjected to automated
thresholding using the Otsu method (Otsu, 1979; Ruifrok and Johnston, 2001; Schindelin et al., 2012). Quantification of UCP1-
positive area was calculated as mm2 and the average of three images per animal was used for statistical analysis.
QUANTIFICATION AND STATISTICAL ANALYSES
The Figure Legends indicate all of the subject numbers/replicates per study; themean ± standard error of themean (SEM) is reported.
The of details the specific statistical analyses based on the conditions and comparisons are listed in each figure legend and employed
methods such as Student’s t test or ANOVA followed by the appropriate and indicated post hoc tests. In the event that variances
were statistically different and thus not meeting the requirement of normal distribution, a non-parametric Mann-Whitney U test
was employed. P values of < 0.05 were determined a priori as the threshold for statistical significance. Data analysis was performed
using GraphPad Prism Software Version 8.02 (GraphPad, San Diego, CA).
DATA AND CODE AVAILABILITY
We have not generated software and datasets in this manuscript.
ADDITIONAL RESOURCES
We have not generated a new website or forum.
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